Randomized trial demonstrates improved chemotherapy efficacy in pancreatic ductal adenocarcinoma using glycopolymer nanoparticles, suggesting new treatment strategies.
, PCG(PTX) demonstrated selective uptake by PDAC cells and enhanced cytotoxicity. Combination with gemcitabine (Gem) further reduced viability and migration while promoting apoptosis. In orthotopic PDAC mouse models, PCG(PTX) + Gem significantly suppressed tumor growth, prolonged survival, and tolerability compared with free PTX. These results demonstrate the promise of PCG glycopolymer nanoparticles as an effective platform for targeted, combination chemotherapy in PDAC.
No takes yet. Share an insight, caveat, or question.
Nakka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: